Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2022 08:30 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces Upcoming MB-106 CD20-Targeted CAR T Data Presentations

WORCESTER, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in...
April 21, 2022 08:30 ET | Source: G1 Therapeutics

G1 Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 4, 2022

RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a...
April 21, 2022 08:00 ET | Source: Unity Biotechnology, Inc.

UNITY Biotechnology to Present Clinical Data at the Association for Research in Vision & Ophthalmology (ARVO) 2022 Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases...
April 21, 2022 08:00 ET | Source: Aileron Therapeutics, Inc.

Aileron Expands Management Team with Appointment of Christopher Zergebel As Vice President, Program Management and Clinical Operations

Mr. Zergebel brings over 20 years of industry experience, primarily focused in oncology, and broad expertise to help Aileron ensure operational excellence Aileron is advancing ALRN-6924 with the goal...
April 21, 2022 08:00 ET | Source: Accelus

Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies

PALM BEACH GARDENS, Fla., April 21, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
April 21, 2022 08:00 ET | Source: Innovative Cellular Therapeutics

Innovative Cellular Therapeutics (ICT) Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

Clinical Data from one research site for GCC19CART, ICT’s lead solid tumor program, for 3rd line plus relapsed/refractory metastatic colorectal cancer (R/R mCRC) shows patients receiving a dose of...
April 21, 2022 08:00 ET | Source: Enzyvant

Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing Capabilities

CAMBRIDGE, Mass. and BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- Enzyvant, a commercial-stage biotechnology company with a focus on regenerative medicines for rare diseases, announced...
April 21, 2022 07:30 ET | Source: OncXerna Therapeutics, Inc.

OncXerna Therapeutics Announces Journal of Clinical Oncology Publication Featuring Phase 1b Data of Navicixizumab Plus Paclitaxel in Ovarian Cancer

Overall response rate (ORR) of 43% and median duration of response of 6 months seen with navicixizumab-paclitaxel combination in heavily pretreated platinum-resistant ovarian cancer patients Xerna™...
April 21, 2022 07:15 ET | Source: VectivBio AG

VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications

BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
April 21, 2022 07:00 ET | Source: MeMed

MeMed to Host Webinar on Best Practice Clinical Use of MeMed BV® for Differentiating Viral from Bacterial Infections on April 28, 2022

HAIFA, Israel, April 21, 2022 – MeMed (or “the Company”), a leader in the emerging field of advanced host-response technologies, today announces that it will host a webinar entitled “Differentiating...